TY - JOUR AU - Oddone, N. AU - Morgan, G. J. AU - Palme, C. E. PY - 2009 DA - 2009// TI - Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival JO - Cancer VL - 9 UR - https://doi.org/10.1002/cncr.24208 DO - 10.1002/cncr.24208 ID - Oddone2009 ER - TY - JOUR AU - Ahmed, S. M. AU - Cohen, E. E. PY - 2007 DA - 2007// TI - Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors JO - Curr Cancer Drug Targets VL - 7 UR - https://doi.org/10.2174/156800907782418293 DO - 10.2174/156800907782418293 ID - Ahmed2007 ER - TY - JOUR AU - Dollner, R. AU - Granzow, C. AU - Neudert, M. AU - Dietz, A. PY - 2006 DA - 2006// TI - Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations JO - Anticancer Res VL - 2B ID - Dollner2006 ER - TY - JOUR AU - Pignon, J. P. AU - Bourhis, J. AU - Domenge, C. AU - Designe, L. PY - 2000 DA - 2000// TI - Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer JO - Lancet VL - 9208 UR - https://doi.org/10.1016/S0140-6736(00)90011-4 DO - 10.1016/S0140-6736(00)90011-4 ID - Pignon2000 ER - TY - JOUR AU - Schrag, D. AU - Garewal, H. S. AU - Burstein, H. J. AU - Samson, D. J. AU - von Hoff, D. D. AU - Somerfield, M. R. PY - 2004 DA - 2004// TI - American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.2004.05.065 DO - 10.1200/JCO.2004.05.065 ID - Schrag2004 ER - TY - JOUR AU - Krause, C. J. AU - Carey, T. E. AU - Ott, R. W. AU - Hurbis, C. AU - McClatchey, K. D. AU - Regezi, J. A. PY - 1981 DA - 1981// TI - Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines JO - Arch Otolaryngol VL - 11 UR - https://doi.org/10.1001/archotol.1981.00790470051012 DO - 10.1001/archotol.1981.00790470051012 ID - Krause1981 ER - TY - JOUR AU - Bier, H. AU - Bergler, W. AU - Mickisch, G. AU - Wesch, H. AU - Ganzer, U. PY - 1990 DA - 1990// TI - Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 JO - Acta Otolaryngol VL - 5-6 UR - https://doi.org/10.3109/00016489009107470 DO - 10.3109/00016489009107470 ID - Bier1990 ER - TY - JOUR AU - Carmichael, J. AU - DeGraff, W. G. AU - Gazdar, A. F. AU - Minna, J. D. AU - Mitchell, J. B. PY - 1987 DA - 1987// TI - Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing JO - Cancer Res VL - 4 ID - Carmichael1987 ER - TY - JOUR AU - Poch, G. AU - Vychodil-Kahr, S. AU - Petru, E. PY - 1999 DA - 1999// TI - Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing JO - Int J Clin Pharmacol Ther VL - 4 ID - Poch1999 ER - TY - JOUR AU - Hafner, D. AU - Heinen, E. AU - Noack, E. PY - 1977 DA - 1977// TI - Mathematical analysis of concentration-response relationships. Method for the evaluation of the ED50 and the number of binding sites per receptor molecule using the logit transformation JO - Arzneimittelforschung VL - 10 ID - Hafner1977 ER - TY - JOUR AU - Scheithauer, W. AU - Clark, G. M. AU - Salmon, S. E. AU - Dorda, W. AU - Shoemaker, R. H. AU - Von Hoff, D. D. PY - 1986 DA - 1986// TI - Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man JO - Cancer Treat Rep VL - 12 ID - Scheithauer1986 ER - TY - JOUR AU - van den Bongard, H. J. AU - Mathot, R. A. AU - Beijnen, J. H. AU - Schellens, J. H. PY - 2000 DA - 2000// TI - Pharmacokinetically guided administration of chemotherapeutic agents JO - Clin Pharmacokinet VL - 5 UR - https://doi.org/10.2165/00003088-200039050-00004 DO - 10.2165/00003088-200039050-00004 ID - van den Bongard2000 ER - TY - JOUR AU - Rousseau, A. AU - Marquet, P. AU - Debord, J. AU - Sabot, C. AU - Lachatre, G. PY - 2000 DA - 2000// TI - Adaptive control methods for the dose individualisation of anticancer agents JO - Clin Pharmacokinet VL - 4 UR - https://doi.org/10.2165/00003088-200038040-00003 DO - 10.2165/00003088-200038040-00003 ID - Rousseau2000 ER - TY - JOUR AU - Perez-Tomas, R. PY - 2006 DA - 2006// TI - Multidrug resistance: retrospect and prospects in anti-cancer drug treatment JO - Curr Med Chem VL - 16 UR - https://doi.org/10.2174/092986706777585077 DO - 10.2174/092986706777585077 ID - Perez-Tomas2006 ER - TY - CHAP AU - Brower, S. L. AU - Fensterer, J. E. AU - Bush, J. E. PY - 2008 DA - 2008// TI - The ChemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy BT - Methods Mol Biol ID - Brower2008 ER - TY - JOUR AU - Cree, I. A. AU - Kurbacher, C. M. AU - Lamont, A. AU - Hindley, A. C. AU - Love, S. PY - 2007 DA - 2007// TI - A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer JO - Anticancer Drugs VL - 9 UR - https://doi.org/10.1097/CAD.0b013e3281de727e DO - 10.1097/CAD.0b013e3281de727e ID - Cree2007 ER - TY - JOUR AU - Abe, R. AU - Ueo, H. AU - Akiyoshi, T. PY - 1994 DA - 1994// TI - Evaluation of MTT assay in agarose for chemosensitivity testing of human cancers: comparison with MTT assay JO - Oncology VL - 5 UR - https://doi.org/10.1159/000227376 DO - 10.1159/000227376 ID - Abe1994 ER - TY - JOUR AU - Strauss, L. AU - Bergmann, C. AU - Szczepanski, M. AU - Gooding, W. AU - Johnson, J. T. AU - Whiteside, T. L. PY - 2007 DA - 2007// TI - A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-07-0472 DO - 10.1158/1078-0432.CCR-07-0472 ID - Strauss2007 ER - TY - JOUR AU - Padron, J. M. AU - van der Wilt, C. L. AU - Smid, K. PY - 2000 DA - 2000// TI - The multilayered postconfluent cell culture as a model for drug screening JO - Crit Rev Oncol Hematol VL - 2-3 UR - https://doi.org/10.1016/S1040-8428(00)00083-4 DO - 10.1016/S1040-8428(00)00083-4 ID - Padron2000 ER - TY - JOUR AU - Kuo, M. T. AU - Chen, H. H. AU - Song, I. S. AU - Savaraj, N. AU - Ishikawa, T. PY - 2007 DA - 2007// TI - The roles of copper transporters in cisplatin resistance JO - Cancer Metastasis Rev VL - 1 UR - https://doi.org/10.1007/s10555-007-9045-3 DO - 10.1007/s10555-007-9045-3 ID - Kuo2007 ER - TY - JOUR AU - Borst, P. AU - Rottenberg, S. AU - Jonkers, J. PY - 2008 DA - 2008// TI - How do real tumors become resistant to cisplatin? JO - Cell Cycle VL - 10 UR - https://doi.org/10.4161/cc.7.10.5930 DO - 10.4161/cc.7.10.5930 ID - Borst2008 ER - TY - JOUR AU - Cullen, K. J. AU - Newkirk, K. A. AU - Schumaker, L. M. AU - Aldosari, N. AU - Rone, J. D. AU - Haddad, B. R. PY - 2003 DA - 2003// TI - Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors JO - Cancer Res VL - 23 ID - Cullen2003 ER - TY - JOUR AU - Hoffmann, T. K. AU - Sonkoly, E. AU - Hauser, U. PY - 2008 DA - 2008// TI - Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma JO - Oral Oncol VL - 12 UR - https://doi.org/10.1016/j.oraloncology.2008.02.006 DO - 10.1016/j.oraloncology.2008.02.006 ID - Hoffmann2008 ER - TY - JOUR AU - Akervall, J. AU - Guo, X. AU - Qian, C. N. PY - 2004 DA - 2004// TI - Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-04-0722 DO - 10.1158/1078-0432.CCR-04-0722 ID - Akervall2004 ER - TY - JOUR AU - Hasegawa, Y. AU - Goto, M. AU - Hanai, N. PY - 2007 DA - 2007// TI - Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer JO - Oral Oncol VL - 8 UR - https://doi.org/10.1016/j.oraloncology.2006.09.003 DO - 10.1016/j.oraloncology.2006.09.003 ID - Hasegawa2007 ER - TY - JOUR AU - Knox, R. J. AU - Friedlos, F. AU - Lydall, D. A. AU - Roberts, J. J. PY - 1986 DA - 1986// TI - Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine (1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA JO - Cancer Res VL - 4 ID - Knox1986 ER - TY - JOUR AU - Bier, H. PY - 1993 DA - 1993// TI - Chemotherapeutic drug resistance in the management of head and neck cancer JO - Eur Arch Otorhinolaryngol VL - 4 ID - Bier1993 ER - TY - JOUR AU - Coley, H. M. AU - Lewandowicz, G. AU - Sargent, J. M. AU - Verrill, M. W. PY - 1997 DA - 1997// TI - Chemosensitivity testing of fresh and continuous tumor cell cultures using lactate dehydrogenase JO - Anticancer Res VL - 1A ID - Coley1997 ER - TY - JOUR AU - Pagliacci, M. C. AU - Spinozzi, F. AU - Migliorati, G. PY - 1993 DA - 1993// TI - Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival JO - Eur J Cancer VL - 11 UR - https://doi.org/10.1016/0959-8049(93)90297-S DO - 10.1016/0959-8049(93)90297-S ID - Pagliacci1993 ER -